This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sites Comment On FDA Draft Guidance Documents Through SCRS

ELLICOTT CITY, Md., Jan. 24, 2013 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is committed to its first pledge that through SCRS sites will have and share their voice for the benefit of the entire clinical research enterprise.  SCRS responded on behalf of its almost 300 site members from over 12 countries with the site's perspective on the two recently issued FDA Draft Guidance Documents: Guidance for IRBs, Clinical Investigators and Sponsors IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed &; Guidance for Industry: Electronic Source Data in Clinical Investigations.

Christine Pierre, President of SCRS, says, "SCRS was founded to represent the global site community and to be actively involved in the dialogue surrounding the clinical research enterprise.  This is a monumental first step for the site community to have collectively contributed to the important discussion surrounding both of these documents.  We are excited that SCRS could facilitate process and look forward to being available to other industry stake holders looking to strengthen their position by ensuring the site's view point is considered." 

Mark Lacy of Benchmark Research and Chair of the Public Policy Committee of SCRS says "through SCRS sites now have a community and leadership to help ensure the sites are contributing to the dialogue that usually impacts the sites operations."

About SCRS

SCRS is the trade association representing the global clinical research sites.  Through the society, sites will become active partners in industry-wide dialogues focused on improving the clinical research enterprise.  SCRS has a mission of advocating on behalf of its members, connecting sites and other stakeholders to build a purposeful community, educating sites and the industry to create a foundation for informed action, and mentoring sites to help sustain and build a strong site foundation.  Membership in SCRS is open to clinical research sites and companies that sponsor or support the work conducted at sites.  Visit www.myscrs.org.   

SOURCE The Society for Clinical Research Sites (SCRS)

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs